- IBDEI33O ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,49513,1,3,0)
- ;;=3^NHL NEC,Extranodal & Solid Organ
- ;;^UTILITY(U,$J,358.3,49513,1,4,0)
- ;;=4^C85.89
- ;;^UTILITY(U,$J,358.3,49513,2)
- ;;=^5001730
- ;;^UTILITY(U,$J,358.3,49514,0)
- ;;=C79.51^^191^2467^33
- ;;^UTILITY(U,$J,358.3,49514,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,49514,1,3,0)
- ;;=3^Secondary Malig Neop Bone
- ;;^UTILITY(U,$J,358.3,49514,1,4,0)
- ;;=4^C79.51
- ;;^UTILITY(U,$J,358.3,49514,2)
- ;;=^5001350
- ;;^UTILITY(U,$J,358.3,49515,0)
- ;;=C79.52^^191^2467^32
- ;;^UTILITY(U,$J,358.3,49515,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,49515,1,3,0)
- ;;=3^Secondary Malig Neop Bone Marrow
- ;;^UTILITY(U,$J,358.3,49515,1,4,0)
- ;;=4^C79.52
- ;;^UTILITY(U,$J,358.3,49515,2)
- ;;=^5001351
- ;;^UTILITY(U,$J,358.3,49516,0)
- ;;=C92.00^^191^2467^26
- ;;^UTILITY(U,$J,358.3,49516,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,49516,1,3,0)
- ;;=3^Myelobl Leuk,Acute,No Remiss
- ;;^UTILITY(U,$J,358.3,49516,1,4,0)
- ;;=4^C92.00
- ;;^UTILITY(U,$J,358.3,49516,2)
- ;;=^5001789
- ;;^UTILITY(U,$J,358.3,49517,0)
- ;;=C92.40^^191^2467^31
- ;;^UTILITY(U,$J,358.3,49517,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,49517,1,3,0)
- ;;=3^Promyelocyt Leuk,Acute,No Remiss
- ;;^UTILITY(U,$J,358.3,49517,1,4,0)
- ;;=4^C92.40
- ;;^UTILITY(U,$J,358.3,49517,2)
- ;;=^5001801
- ;;^UTILITY(U,$J,358.3,49518,0)
- ;;=C92.50^^191^2467^28
- ;;^UTILITY(U,$J,358.3,49518,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,49518,1,3,0)
- ;;=3^Myelomonocyt Leuk,Acute,No Remiss
- ;;^UTILITY(U,$J,358.3,49518,1,4,0)
- ;;=4^C92.50
- ;;^UTILITY(U,$J,358.3,49518,2)
- ;;=^5001804
- ;;^UTILITY(U,$J,358.3,49519,0)
- ;;=C78.7^^191^2467^37
- ;;^UTILITY(U,$J,358.3,49519,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,49519,1,3,0)
- ;;=3^Secondary Malig Neop Liver & Intrahep BD
- ;;^UTILITY(U,$J,358.3,49519,1,4,0)
- ;;=4^C78.7
- ;;^UTILITY(U,$J,358.3,49519,2)
- ;;=^5001339
- ;;^UTILITY(U,$J,358.3,49520,0)
- ;;=C91.10^^191^2467^5
- ;;^UTILITY(U,$J,358.3,49520,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,49520,1,3,0)
- ;;=3^Lymphocyt Leuk B-Cell,Chr,No Remiss
- ;;^UTILITY(U,$J,358.3,49520,1,4,0)
- ;;=4^C91.10
- ;;^UTILITY(U,$J,358.3,49520,2)
- ;;=^5001765
- ;;^UTILITY(U,$J,358.3,49521,0)
- ;;=D46.9^^191^2467^27
- ;;^UTILITY(U,$J,358.3,49521,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,49521,1,3,0)
- ;;=3^Myelodysplastic Syndrome,Unspec
- ;;^UTILITY(U,$J,358.3,49521,1,4,0)
- ;;=4^D46.9
- ;;^UTILITY(U,$J,358.3,49521,2)
- ;;=^334031
- ;;^UTILITY(U,$J,358.3,49522,0)
- ;;=C79.31^^191^2467^34
- ;;^UTILITY(U,$J,358.3,49522,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,49522,1,3,0)
- ;;=3^Secondary Malig Neop Brain
- ;;^UTILITY(U,$J,358.3,49522,1,4,0)
- ;;=4^C79.31
- ;;^UTILITY(U,$J,358.3,49522,2)
- ;;=^5001347
- ;;^UTILITY(U,$J,358.3,49523,0)
- ;;=C79.32^^191^2467^35
- ;;^UTILITY(U,$J,358.3,49523,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,49523,1,3,0)
- ;;=3^Secondary Malig Neop Cerebral Meninges
- ;;^UTILITY(U,$J,358.3,49523,1,4,0)
- ;;=4^C79.32
- ;;^UTILITY(U,$J,358.3,49523,2)
- ;;=^5001348
- ;;^UTILITY(U,$J,358.3,49524,0)
- ;;=G89.3^^191^2467^30
- ;;^UTILITY(U,$J,358.3,49524,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,49524,1,3,0)
- ;;=3^Neoplasm Related Pain
- ;;^UTILITY(U,$J,358.3,49524,1,4,0)
- ;;=4^G89.3
- ;;^UTILITY(U,$J,358.3,49524,2)
- ;;=^5004159
- ;;^UTILITY(U,$J,358.3,49525,0)
- ;;=C79.82^^191^2467^36
- ;;^UTILITY(U,$J,358.3,49525,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,49525,1,3,0)
- ;;=3^Secondary Malig Neop Genital Organs
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI33O 3762 printed Jan 18, 2025@03:42:22 Page 2
- IBDEI33O ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,49513,1,3,0)
- +2 ;;=3^NHL NEC,Extranodal & Solid Organ
- +3 ;;^UTILITY(U,$J,358.3,49513,1,4,0)
- +4 ;;=4^C85.89
- +5 ;;^UTILITY(U,$J,358.3,49513,2)
- +6 ;;=^5001730
- +7 ;;^UTILITY(U,$J,358.3,49514,0)
- +8 ;;=C79.51^^191^2467^33
- +9 ;;^UTILITY(U,$J,358.3,49514,1,0)
- +10 ;;=^358.31IA^4^2
- +11 ;;^UTILITY(U,$J,358.3,49514,1,3,0)
- +12 ;;=3^Secondary Malig Neop Bone
- +13 ;;^UTILITY(U,$J,358.3,49514,1,4,0)
- +14 ;;=4^C79.51
- +15 ;;^UTILITY(U,$J,358.3,49514,2)
- +16 ;;=^5001350
- +17 ;;^UTILITY(U,$J,358.3,49515,0)
- +18 ;;=C79.52^^191^2467^32
- +19 ;;^UTILITY(U,$J,358.3,49515,1,0)
- +20 ;;=^358.31IA^4^2
- +21 ;;^UTILITY(U,$J,358.3,49515,1,3,0)
- +22 ;;=3^Secondary Malig Neop Bone Marrow
- +23 ;;^UTILITY(U,$J,358.3,49515,1,4,0)
- +24 ;;=4^C79.52
- +25 ;;^UTILITY(U,$J,358.3,49515,2)
- +26 ;;=^5001351
- +27 ;;^UTILITY(U,$J,358.3,49516,0)
- +28 ;;=C92.00^^191^2467^26
- +29 ;;^UTILITY(U,$J,358.3,49516,1,0)
- +30 ;;=^358.31IA^4^2
- +31 ;;^UTILITY(U,$J,358.3,49516,1,3,0)
- +32 ;;=3^Myelobl Leuk,Acute,No Remiss
- +33 ;;^UTILITY(U,$J,358.3,49516,1,4,0)
- +34 ;;=4^C92.00
- +35 ;;^UTILITY(U,$J,358.3,49516,2)
- +36 ;;=^5001789
- +37 ;;^UTILITY(U,$J,358.3,49517,0)
- +38 ;;=C92.40^^191^2467^31
- +39 ;;^UTILITY(U,$J,358.3,49517,1,0)
- +40 ;;=^358.31IA^4^2
- +41 ;;^UTILITY(U,$J,358.3,49517,1,3,0)
- +42 ;;=3^Promyelocyt Leuk,Acute,No Remiss
- +43 ;;^UTILITY(U,$J,358.3,49517,1,4,0)
- +44 ;;=4^C92.40
- +45 ;;^UTILITY(U,$J,358.3,49517,2)
- +46 ;;=^5001801
- +47 ;;^UTILITY(U,$J,358.3,49518,0)
- +48 ;;=C92.50^^191^2467^28
- +49 ;;^UTILITY(U,$J,358.3,49518,1,0)
- +50 ;;=^358.31IA^4^2
- +51 ;;^UTILITY(U,$J,358.3,49518,1,3,0)
- +52 ;;=3^Myelomonocyt Leuk,Acute,No Remiss
- +53 ;;^UTILITY(U,$J,358.3,49518,1,4,0)
- +54 ;;=4^C92.50
- +55 ;;^UTILITY(U,$J,358.3,49518,2)
- +56 ;;=^5001804
- +57 ;;^UTILITY(U,$J,358.3,49519,0)
- +58 ;;=C78.7^^191^2467^37
- +59 ;;^UTILITY(U,$J,358.3,49519,1,0)
- +60 ;;=^358.31IA^4^2
- +61 ;;^UTILITY(U,$J,358.3,49519,1,3,0)
- +62 ;;=3^Secondary Malig Neop Liver & Intrahep BD
- +63 ;;^UTILITY(U,$J,358.3,49519,1,4,0)
- +64 ;;=4^C78.7
- +65 ;;^UTILITY(U,$J,358.3,49519,2)
- +66 ;;=^5001339
- +67 ;;^UTILITY(U,$J,358.3,49520,0)
- +68 ;;=C91.10^^191^2467^5
- +69 ;;^UTILITY(U,$J,358.3,49520,1,0)
- +70 ;;=^358.31IA^4^2
- +71 ;;^UTILITY(U,$J,358.3,49520,1,3,0)
- +72 ;;=3^Lymphocyt Leuk B-Cell,Chr,No Remiss
- +73 ;;^UTILITY(U,$J,358.3,49520,1,4,0)
- +74 ;;=4^C91.10
- +75 ;;^UTILITY(U,$J,358.3,49520,2)
- +76 ;;=^5001765
- +77 ;;^UTILITY(U,$J,358.3,49521,0)
- +78 ;;=D46.9^^191^2467^27
- +79 ;;^UTILITY(U,$J,358.3,49521,1,0)
- +80 ;;=^358.31IA^4^2
- +81 ;;^UTILITY(U,$J,358.3,49521,1,3,0)
- +82 ;;=3^Myelodysplastic Syndrome,Unspec
- +83 ;;^UTILITY(U,$J,358.3,49521,1,4,0)
- +84 ;;=4^D46.9
- +85 ;;^UTILITY(U,$J,358.3,49521,2)
- +86 ;;=^334031
- +87 ;;^UTILITY(U,$J,358.3,49522,0)
- +88 ;;=C79.31^^191^2467^34
- +89 ;;^UTILITY(U,$J,358.3,49522,1,0)
- +90 ;;=^358.31IA^4^2
- +91 ;;^UTILITY(U,$J,358.3,49522,1,3,0)
- +92 ;;=3^Secondary Malig Neop Brain
- +93 ;;^UTILITY(U,$J,358.3,49522,1,4,0)
- +94 ;;=4^C79.31
- +95 ;;^UTILITY(U,$J,358.3,49522,2)
- +96 ;;=^5001347
- +97 ;;^UTILITY(U,$J,358.3,49523,0)
- +98 ;;=C79.32^^191^2467^35
- +99 ;;^UTILITY(U,$J,358.3,49523,1,0)
- +100 ;;=^358.31IA^4^2
- +101 ;;^UTILITY(U,$J,358.3,49523,1,3,0)
- +102 ;;=3^Secondary Malig Neop Cerebral Meninges
- +103 ;;^UTILITY(U,$J,358.3,49523,1,4,0)
- +104 ;;=4^C79.32
- +105 ;;^UTILITY(U,$J,358.3,49523,2)
- +106 ;;=^5001348
- +107 ;;^UTILITY(U,$J,358.3,49524,0)
- +108 ;;=G89.3^^191^2467^30
- +109 ;;^UTILITY(U,$J,358.3,49524,1,0)
- +110 ;;=^358.31IA^4^2
- +111 ;;^UTILITY(U,$J,358.3,49524,1,3,0)
- +112 ;;=3^Neoplasm Related Pain
- +113 ;;^UTILITY(U,$J,358.3,49524,1,4,0)
- +114 ;;=4^G89.3
- +115 ;;^UTILITY(U,$J,358.3,49524,2)
- +116 ;;=^5004159
- +117 ;;^UTILITY(U,$J,358.3,49525,0)
- +118 ;;=C79.82^^191^2467^36
- +119 ;;^UTILITY(U,$J,358.3,49525,1,0)
- +120 ;;=^358.31IA^4^2
- +121 ;;^UTILITY(U,$J,358.3,49525,1,3,0)
- +122 ;;=3^Secondary Malig Neop Genital Organs